Last reviewed · How we verify
NCT05154461
Intestinal Ketone Bodies Interfere With the Glycemic Control
NA trial testing Alginate in Healthy Adult Volunteers in 8 participants. Completed in 1 September 2022.
1 July 2022
Quick facts
| Lead sponsor | Göteborg University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 8 |
| Start date | 5 December 2021 |
| Primary completion | 1 July 2022 |
| Estimated completion | 1 September 2022 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- Alginate — full drug profile →
- Pea-protein
Conditions studied
- Healthy Adult Volunteers — all drugs for Healthy Adult Volunteers →
Sponsor
Göteborg University
Who can join
Adults 18 to 65, any sex, with Healthy Adult Volunteers. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The ketone body (KB) ß-hydroxybutyrate will be given to eight fasting healthy volunteers of both sexes in order to observe the effects after an oral glucose tolerance test (OGTT) over 2 h. Then, a standard lunch will be served at 12.00, as well as an afternoon snack at 15.00. Each participant will be its own control and participates in a randomised two-way cross over design; the KB are released in the stomach-duodenum, or in the ileum-colon. Peripheral blood samples are taken for endpoint GLP-1 analyses.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05154461
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Alginate
Trials testing the same drug.
- NCT05629143 — Primary carE PPi dEprescRibing Trial · Phase 4 · active not recruiting
- NCT04589273 — The Effect of Alginate Supplementation on Weight Management · NA · unknown
- NCT03635372 — A Comparison of Effectiveness of Oral Sucrolfate, Alginate and Hydrotalcide in Dispeptic Pain Treatment · Phase 4 · completed
Other recruiting trials for Healthy Adult Volunteers
Currently open trials in the same condition.
- NCT06681389 — A Study of NP-201 Acetate Injection in Healthy Adult Volunteers and in Patients With Mild-To-Moderate Active Ulcerative · Phase 1 · recruiting
Other Göteborg University trials
Trials by the same sponsor.
- NCT07260604 — HIFEM for Incontinence After Menopause High-Intensity Focused Electromagnetic (HIFEM) · NA · not yet recruiting
- NCT07401420 — Life Sustaining Treatments in Critically Ill Children · not yet recruiting
- NCT07213245 — Metabolic Effects of Short-term Ultra-processed Food Intake (MEST-UPF) · NA · recruiting
- NCT07178405 — Effects of Meal Characteristics on Appetite · NA · completed
- NCT07172841 — Non-invasive Diagnostics of Shunt Obstruction in Adult Hydrocephalus · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05154461 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Göteborg University
- Last refreshed: 30 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05154461.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing